No Data
No Data
No Data
No Data
No Data
Analysts Offer Insights on Healthcare Companies: Dexcom (DXCM), OptimizeRx (OPRX) and AbbVie (ABBV)
TipRanksApr 29 17:50
OptimizeRx (OPRX) Stock Valuation Soars: Insights Unveiled
OptimizeRx Corp. (NASDAQ: OPRX) shares surged 14.32% to $10.06 on US stock exchanges today. The current-market rise followed a business update and preliminary financial results announcement, attracting attention from analysts and investors. OptimizeRx (OPRX) has released preliminary, unaudited financial statistics for many key performance indicators (KPIs) for the first quarter of 2024 in addition to ...
Stocks TelegraphApr 27 02:23
Applied Dna Sciences, OptimizeRx, SCWorx Among Healthcare Movers
Seeking AlphaApr 26 22:00
OptimizeRx Corporation Says 1Q24 Revenue Expected To Grow Over 40% YoY And Come In Between $18.5M-$19.2M Vs. $17.03M Estimate; Company Says DAAP Adoption And Cross Selling Activities Are Tracking Ahead Of Internal Expectations
For the first quarter, the Company expects revenue to increase over 40% year-over-year and come in between $18.5 million and $19.2 million with a GAAP net loss and Adjusted EBITDA loss between $(8.2)
BenzingaApr 26 19:37
OptimizeRx Provides Business Update and Sets First Quarter 2024 Conference Call for May 14, 2024 at 4:30 P.m. ET
1Q24 revenue expected to grow over 40% year-over-year and come in between $18.5 - $19.2 million First quarter revenue and adjusted EBITDA to come in ahead of consensus DAAP adoption and cross selling activities are
GlobeNewswireApr 26 19:30
Down -18.75% in 4 Weeks, Here's Why You Should You Buy the Dip in OptimizeRx (OPRX)
Yahoo FinanceApr 22 21:35
No Data
No Data